Casak SJ - Search Results

1

FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer.

Casak SJ, Horiba MN, Yuan M, Cheng J, Lemery SJ, Shen YL, Fu W, Moore JN, Li Y, Bi Y, Auth D, Fesenko N, Kluetz PG, Pazdur R, Fashoyin-Aje LA. Casak SJ, et al. Clin Cancer Res. 2023 Nov 1;29(21):4326-4330. doi: 10.1158/1078-0432.CCR-23-1041. Clin Cancer Res. 2023. PMID: 37318379 Free PMC article.

2

Phase II window of idarubicin in children with extraocular retinoblastoma.

Chantada GL, Fandiño A, Mato G, Casak S. Chantada GL, et al. J Clin Oncol. 1999 Jun;17(6):1847-50. doi: 10.1200/JCO.1999.17.6.1847. J Clin Oncol. 1999. PMID: 10561224 Clinical Trial.

3

Treatment of overt extraocular retinoblastoma.

Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Chantada G, et al. Med Pediatr Oncol. 2003 Mar;40(3):158-61. doi: 10.1002/mpo.10249. Med Pediatr Oncol. 2003. PMID: 12518344

4

Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy.

Zubizarreta P, Felice MS, Alfaro E, Fraquelli L, Casak S, Quinteros R, Cygler A, Gallego M, Pérez LE, Sackmann-Muriel F. Zubizarreta P, et al. Leuk Res. 1998 May;22(5):465-72. doi: 10.1016/s0145-2126(98)00016-2. Leuk Res. 1998. PMID: 9652734

5

Paediatric oncology in Argentina: medical and ethical issues.

Scopinaro MJ, Casak SJ. Scopinaro MJ, et al. Among authors: casak sj. Lancet Oncol. 2002 Feb;3(2):111-7. doi: 10.1016/s1470-2045(02)00653-8. Lancet Oncol. 2002. PMID: 11902522

6

Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.

Sackmann-Muriel F, Zubizarreta P, Gallo G, Scopinaro M, Alderete D, Alfaro E, Casak S, Chantada G, Felice MS, Quinteros R. Sackmann-Muriel F, et al. Med Pediatr Oncol. 1997 Dec;29(6):544-52. doi: 10.1002/(sici)1096-911x(199712)29:6<544::aid-mpo5>3.0.co;2-k. Med Pediatr Oncol. 1997. PMID: 9324342 Clinical Trial.

7

Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina.

Chantada G, Casak S, Alderete D, Zubizarreta P, Gallo G, Muriel FS. Chantada G, et al. Med Pediatr Oncol. 2003 Nov;41(5):488-90. doi: 10.1002/mpo.10288. Med Pediatr Oncol. 2003. PMID: 14515400 No abstract available.

8

Children with fever of unknown origin in Argentina: an analysis of 113 cases.

Chantada G, Casak S, Plata JD, Pociecha J, Bologna R. Chantada G, et al. Pediatr Infect Dis J. 1994 Apr;13(4):260-3. doi: 10.1097/00006454-199404000-00003. Pediatr Infect Dis J. 1994. PMID: 8036040

9

Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country.

Chantada GL, Fandiño AC, Raslawski EC, Manzitti J, de Dávila MT, Casak SJ, Scopinaro MJ, Schvartzman E. Chantada GL, et al. Among authors: casak sj. Pediatr Blood Cancer. 2005 May;44(5):455-60. doi: 10.1002/pbc.20259. Pediatr Blood Cancer. 2005. PMID: 15558702

10

Activity of topotecan in retinoblastoma.

Chantada GL, Fandiño AC, Casak SJ, Mato G, Manzitti J, Schvartzman E. Chantada GL, et al. Among authors: casak sj. Ophthalmic Genet. 2004 Mar;25(1):37-43. doi: 10.1076/opge.25.1.37.28996. Ophthalmic Genet. 2004. PMID: 15255113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters